Business
Recce share price on watch following COVID-19 antiviral selection – Motley Fool Australia
The Recce share price is on watch after the company announced selection by CSIRO for trials to treat SARS-CoV-2, the virus that causes COVID-19.
The Recce Pharmaceuticals Ltd (ASX: RCE) share price is on watch today after the company announced it has entered into an antiviral Sars-CoV-2 screening program. Recce (pronounced ‘recky’) is pioneer…
Continue Reading
-
Business21 hours agoRetirement costs rise $1,400 a year for couples and $900 for singles
-
Business23 hours agoWhere will BHP shares be in 3 years?
-
Business22 hours agoHow to know when to buy, hold, or sell ASX shares
-
Noosa News20 hours agoVictorian apiarists finding it harder to access public land ‘vital’ for bees